N
BNGO icon

Nuveen’s Bionano Genomics BNGO Stock Holding History

Nuveen’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,904
Closed -$1.93M – 3218
2023
Q1 		$1.93M Buy
2,904
+1,356
+88% +$1.2M ﹤0.01% 2345
2022
Q4 		$1.36M Sell
1,548
-197
-11% -$248K ﹤0.01% 2556
2022
Q3 		$1.92M Sell
1,745
-8
-0.5% -$10.6K ﹤0.01% 2418
2022
Q2 		$1.45M Buy
1,753
+333
+23% +$343K ﹤0.01% 2607
2022
Q1 		$1.94M Sell
1,420
-303
-18% -$409K ﹤0.01% 2517
2021
Q4 		$3.09M Sell
1,723
-1,999
-54% -$5.35M ﹤0.01% 2360
2021
Q3 		$12.3M Sell
3,722
-1,318
-26% -$4.61M ﹤0.01% 1638
2021
Q2 		$22.2M Buy
+5,040
New +$19.9M 0.01% 1284

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's BNGO Position: Q2 2023 in Review

Nuveen sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 2,904 shares — an estimated $1.93M sold.

Nuveen first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $22.2M in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Nuveen reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 2,904 Bionano Genomics shares in Q2 2023, an estimated $1.93M.
  • Nuveen first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Nuveen's Bionano Genomics position peaked at $22.2M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.